# Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

> **NCT06569108** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Suzhou Alphamab Co., Ltd.** · enrollment: 125 (actual)

## Conditions studied

- Hemophilia A Without Inhibitor
- Hemophilia B Without Inhibitor

## Interventions

- **DRUG:** KN057

## Key facts

- **NCT ID:** NCT06569108
- **Lead sponsor:** Suzhou Alphamab Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-10-15
- **Final completion:** 2026-12-15
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06569108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06569108, "Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06569108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*